Skip to Content

EZR-104 Approval Status

FDA Approved: No
Brand name: EZR-104
Generic name: valsartan
Company: Ezra Innovations, LLC
Treatment for: High Blood Pressure, Heart Failure

EZR-104 (valsartan) is a novel formulation of the angiotensin receptor blocker valsartan, with patented RubiretenTM delivery technology, in development for the treatment of hypertension and heart failure.

Development Status and FDA Approval Process for EZR-104

DateArticle
Jan 18, 2017Ezra Announces FDA Acceptance of Filing of New Drug Application For EZR-104 for the Treatment of Hypertension and Heart Failure

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide